June 2, 1999
American Chemical Society
Scientists at Schering-Plough Research Institute are reporting what they say is the first atomic view that shows how a promising new class of cancer-fighting drugs works. The discovery may point the way to faster, better refinement of the drugs, according to the researchers. Several pharmaceutical companies are in a race to develop so-called farnesyl protein transferase (FPT) inhibitors, which incapacitate an enzyme recently found to activate many types of cancer.
Visualization of action could lead to development of more potent, less toxic drugs
The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.
Cite This Page:
American Chemical Society. "Details Of Promising Cancer Therapy Shows For The First Time." ScienceDaily. ScienceDaily, 2 June 1999. <www.sciencedaily.com/releases/1999/06/990602072418.htm>.
American Chemical Society. (1999, June 2). Details Of Promising Cancer Therapy Shows For The First Time. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/1999/06/990602072418.htm
American Chemical Society. "Details Of Promising Cancer Therapy Shows For The First Time." ScienceDaily. www.sciencedaily.com/releases/1999/06/990602072418.htm (accessed April 23, 2014).